Hepatic macrophage activation and the LPS pathway in patients with alcoholic hepatitis: a prospective cohort study

Thomas Damgaard Sandahl1, Henning Grønbaek1, Holger Jon Møller2

  • 1Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.

Abstract

Insights

In human alcoholic hepatitis (AH), hepatic macrophages show significant inflammatory activation, likely driven by lipopolysaccharide (LPS). This macrophage activation is a predictor of mortality and a potential therapeutic target.

Area of Science:

  • Hepatology
  • Immunology
  • Gastroenterology

Background:

  • Inflammatory activation of Kupffer cells by lipopolysaccharide (LPS) is crucial in animal models of alcoholic liver disease.
  • This process has not been systematically studied in human alcoholic hepatitis (AH).

Purpose of the Study:

  • To investigate the longitudinal changes in hepatic macrophage activation and LPS pathway components in patients with AH.
  • To assess the correlation of these markers with disease severity and mortality.

Main Methods:

  • Longitudinal study of 50 AH patients over 30 days, with controls including 26 stable cirrhotics and 20 healthy individuals.
  • Measurement of plasma soluble CD163 (sCD163), liver CD163 expression, plasma LPS, sCD14, and LPS-binding protein (LBP).
  • Correlation analysis with clinical scores (Glasgow AH, MELD, Child-Pugh) and 84-day mortality.

Main Results:

  • Patients with AH exhibited significantly elevated sCD163 and LPS pathway markers compared to controls.
  • sCD163 levels correlated with AH severity scores.
  • Markers decreased during follow-up but remained elevated; sCD163 independently predicted 84-day mortality.

Conclusions:

  • Human AH involves significant hepatic macrophage activation, likely mediated by the LPS pathway.
  • Hepatic macrophages represent a potential therapeutic target for biological treatment of AH.

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
29
Inflammation01:38

Inflammation

Overview
46.1K
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
23
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.1K
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
22
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
24